News

Applied Clinical Trials Online17h

Dynavax Technologies’ Investigational Shingles Vaccine Achieves Complete Antibody Response in Phase I/II Shingles Trial

Results from the first part of a Phase I/II trial (NCT06569823) showed that Z-1018 generated immune responses comparable to ...

Dynavax’s shingles vaccine shows promise in trial against GSK’s Shingrix

Dynavax Technologies has revealed promising topline outcomes from the initial part of its Phase I/II clinical trial, ...